Deep Brain Stimulator Market

Deep Brain Stimulator Market
Deep Brain Stimulation (DMS) is a neosurgical procedure which helps to treat a variety of disabling
neurological symptoms. It involves the implantation of a battery-operated medical device called
neurostimulator which sends electrical signals to specific parts of brain that control movement and
affective disorders like pain, mood, weight and awakening. This procedure also helps in treating essential
tremor, a common neurological movement disorder. DMS system consists of three components: a thin,
insulated wire, called a lead or electrode that is placed into the brain, the neurostimulator which puts out
the electric current and is generally placed under the skin near the collarbone and another thin, insulated
wire, called an extension which connects the lead to the neurostimulator. The neurostimulator device is
also referred to as ‘brain pacemaker’. FDA approved DMS as a treatment for essential tremor in 1997, for
Parkinson’s disease in 2002. Before this procedure, a neurosurgeon uses either MRI or CT scanning to
detect the exact target area within the brain where the electric signals will generate the Parkinson’s
disease symptoms.
Deep Brain Stimulator Market: Drivers and Restraints
Increasing incidence of Parkinson’s disease is the main driving force for the fast growth of deep brain
stimulation device market. Deep brain stimulation does not involve destruction of any part of the brain
and thus, has fewer complications than thalamotomy and pallidotomy.Moreover this electrical injection
is adjustable and can be changed as the person’s disease change or his or her response to medication
change. No further surgery is needed to make the adjustments. All these has led to the growth of deep
brain stimulation device market. However, with any surgical procedure there involves risk. The
implantation of any foreign object in the body leads to increased risk of infection. If the battery fails then
©2015 Future Market Insights, All Rights Reserved 4